Steris (NYSE: STE) reported Q3 EPS of $0.98, $0.04 better than the analyst estimate of $0.94. Revenue for the quarter came in at $618.7 million versus the consensus estimate of $617.35 million.

GUIDANCE:

Steris sees FY2016 EPS of $3.48-$3.55, versus the consensus of $3.51.

For earnings history and earnings-related data on Steris (STE) click here.